Fanni Päkkilä1, Tuija Männistö, Anneli Pouta, Anna-Liisa Hartikainen, Aimo Ruokonen, Heljä-Marja Surcel, Aini Bloigu, Marja Vääräsmäki, Marjo-Riitta Järvelin, Irma Moilanen, Eila Suvanto. 1. Departments of Obstetrics and Gynecology (F.P., A.-L.H., M.V., E.S.) and Clinical Chemistry (A.R.), and Clinic of Child Psychiatry (I.M.), University of Oulu and Oulu University Hospital, 90029 OYS, Oulu, Finland; Institute of Health Sciences (F.P., M.-R.J.), University of Oulu, 90220 Oulu, Finland; Department of Children, Young People, and Families (F.P., A.P., H.-M.S., A.B., M.-R.J.), National Institute for Health and Welfare, 00271 Helsinki, Finland; Epidemiology Branch (T.M.), Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892; and Department of Epidemiology and Biostatistics (M.-R.J.), Imperial College London, London SW7 2AZ, United Kingdom.
Abstract
CONTEXT: Maternal hypothyroidism during pregnancy is associated with adverse neuropsychological development in the offspring. OBJECTIVE: The objective of the study was to evaluate the effect of maternal thyroid dysfunction during pregnancy on a child's attention-deficit/hyperactivity disorder (ADHD) symptoms. DESIGN, SETTINGS, AND PARTICIPANTS: The prospective, population-based Northern Finland Birth Cohort 1986 (9362 pregnancies; 9479 infants) included analysis of maternal TSH, free T4, and thyroid-peroxidase antibodies (TPO-Abs) from early pregnancy samples (5791 women). Teachers evaluated the children's ADHD symptoms at 8 years using the Rutter B2 scale (5131 mother-child pairs), in which a high score indicated probable psychiatric disorders and three questions focused directly on ADHD. MAIN OUTCOME MEASURES: The odds ratios (ORs) and 95% confidence intervals (95% CIs) of child having ADHD symptoms and/or a high Rutter B2 score after exposure to increases in maternal TSH levels (after logarithmic transformation), low free T4 levels, and TPO-Ab positivity was tested with logistic regression, adjusting for maternal/family covariates. Data were stratified by the child's gender due to interaction. RESULTS: Among girls the odds of inattention (OR 1.18, 95% CI 1.02-1.37), high Rutter B2 total score (OR 1.23, 95% CI 1.03-1.48), and combined ADHD symptoms (OR 1.39, 95% CI 1.07-1.80) significantly increased with every natural log increase in maternal TSH concentrations. Such findings were not evident in boys. No associations were seen between ADHD symptoms and low maternal free T4 levels or TPO-Ab positivity. CONCLUSIONS: Increases in maternal TSH in early pregnancy showed weak but significant association with girls' ADHD symptoms.
CONTEXT: Maternal hypothyroidism during pregnancy is associated with adverse neuropsychological development in the offspring. OBJECTIVE: The objective of the study was to evaluate the effect of maternal thyroid dysfunction during pregnancy on a child's attention-deficit/hyperactivity disorder (ADHD) symptoms. DESIGN, SETTINGS, AND PARTICIPANTS: The prospective, population-based Northern Finland Birth Cohort 1986 (9362 pregnancies; 9479 infants) included analysis of maternal TSH, free T4, and thyroid-peroxidase antibodies (TPO-Abs) from early pregnancy samples (5791 women). Teachers evaluated the children's ADHD symptoms at 8 years using the Rutter B2 scale (5131 mother-child pairs), in which a high score indicated probable psychiatric disorders and three questions focused directly on ADHD. MAIN OUTCOME MEASURES: The odds ratios (ORs) and 95% confidence intervals (95% CIs) of child having ADHD symptoms and/or a high Rutter B2 score after exposure to increases in maternal TSH levels (after logarithmic transformation), low free T4 levels, and TPO-Ab positivity was tested with logistic regression, adjusting for maternal/family covariates. Data were stratified by the child's gender due to interaction. RESULTS: Among girls the odds of inattention (OR 1.18, 95% CI 1.02-1.37), high Rutter B2 total score (OR 1.23, 95% CI 1.03-1.48), and combined ADHD symptoms (OR 1.39, 95% CI 1.07-1.80) significantly increased with every natural log increase in maternal TSH concentrations. Such findings were not evident in boys. No associations were seen between ADHD symptoms and low maternal free T4 levels or TPO-Ab positivity. CONCLUSIONS: Increases in maternal TSH in early pregnancy showed weak but significant association with girls' ADHD symptoms.
Authors: Jens Henrichs; Jacoba J Bongers-Schokking; Jacqueline J Schenk; Akhgar Ghassabian; Henk G Schmidt; Theo J Visser; Herbert Hooijkaas; Sabine M P F de Muinck Keizer-Schrama; Albert Hofman; Vincent V W Jaddoe; Willy Visser; Eric A P Steegers; Frank C Verhulst; Yolanda B de Rijke; Henning Tiemeier Journal: J Clin Endocrinol Metab Date: 2010-06-09 Impact factor: 5.958
Authors: Akhgar Ghassabian; Jacoba J Bongers-Schokking; Jens Henrichs; Vincent W V Jaddoe; Theo J Visser; Willy Visser; Sabine M P F de Muinck Keizer-Schrama; Herbert Hooijkaas; Eric A P Steegers; Albert Hofman; Frank C Verhulst; Jan van der Ende; Yolanda B de Rijke; Henning Tiemeier Journal: Pediatr Res Date: 2011-05 Impact factor: 3.756
Authors: Eva Ausó; Rosalía Lavado-Autric; Estela Cuevas; Francisco Escobar Del Rey; Gabriella Morreale De Escobar; Pere Berbel Journal: Endocrinology Date: 2004-04-15 Impact factor: 4.736
Authors: Susan L Smalley; James J McGough; Irma K Moilanen; Sandra K Loo; Anja Taanila; Hanna Ebeling; Tuula Hurtig; Marika Kaakinen; Lorie A Humphrey; James T McCracken; Teppo Varilo; May H Yang; Stanley F Nelson; Leena Peltonen; Marjo-Riitta Järvelin Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-12 Impact factor: 8.829
Authors: Gro Dehli Villanger; Emily Learner; Matthew P Longnecker; Helga Ask; Heidi Aase; R Thomas Zoeller; Gun P Knudsen; Ted Reichborn-Kjennerud; Pål Zeiner; Stephanie M Engel Journal: Epidemiology Date: 2017-05 Impact factor: 4.822
Authors: Brett T Doherty; Kate Hoffman; Alexander P Keil; Stephanie M Engel; Heather M Stapleton; Barbara D Goldman; Andrew F Olshan; Julie L Daniels Journal: Neurotoxicology Date: 2019-04-03 Impact factor: 4.294
Authors: Samantha S M Drover; Gro D Villanger; Heidi Aase; Thea S Skogheim; Matthew P Longnecker; R Thomas Zoeller; Ted Reichborn-Kjennerud; Gun P Knudsen; Pål Zeiner; Stephanie M Engel Journal: Epidemiology Date: 2019-01 Impact factor: 4.822